Skip Navigation



QJM Advance Access published online on August 6, 2007

QJM, doi:10.1093/qjmed/hcm062
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/9/551    most recent
hcm062v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nitsch, D.
Right arrow Articles by Feest, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nitsch, D.
Right arrow Articles by Feest, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Patients with diabetic nephropathy on renal replacement therapy in England and Wales

D. Nitsch1, R. Burden2, R. Steenkamp3, D. Ansell3, C. Byrne2,3, F. Caskey4, P. Roderick5 and T. Feest3,4

From the 1Department of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, 2Renal Unit, Nottingham City Hospital, Nottingham, 3UK Renal Registry and 4Renal Unit, Southmead Hospital, Bristol, and 5Applied Epidemiology Group, University of Southampton, Southampton General Hospital, Southampton, UK

Address correspondence to Dr D. Nitsch, Department of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK. email: dorothea.nitsch{at}lshtm.ac.uk

Received 1 March 2007 and in revised form 30 April 2007


   Abstract

Background: The incidence of patients with diabetic nephropathy (DN) who start renal replacement therapy (RRT) is increasing.

Aim: To describe the characteristics and survival of patients with DN starting RRT in the UK

Design: Retrospective cohort study.

Methods: We analysed data for incident patients on RRT in centres participating in the Renal Association UK Renal Registry (UKRR), 1997 –2004, comparing DN vs. non-DN patients with regard to survival, social deprivation, ethnicity, gender, and age, using Cox regression models.

Results: DN was the most common renal disease (19%) in the 20 532 patients starting RRT. The majority of patients with DN (77%) were Caucasian. Within the Caucasian population, DN patients were more likely to be from a socially deprived area (p < 0.0001). About 20% were referred <3 months before starting RRT. The difference in crude survival was greatest in younger patients (5-year survival was 56% (DN) vs. 85% (non-DN) in patients aged 18–54 years, and 17% (DN) vs. 28% (non-DN) in patients aged >=65 years). Despite adjusting for gender, age, treatment modality, social deprivation, referral and co-morbidities, the long-term prognosis for DN patients aged 18–54 years was worse (adjusted hazard ratio 2.13, 95%CI 1.23–3.67) than for older age groups.

Discussion: Patients with DN starting RRT are more likely to come from socially deprived areas. Relative risk of death is greatest in working-age DN patients and is not fully explained by recorded co-morbidity. This emphasizes the need for focused diabetes care in poorer areas, and assessment of quality of care of diabetic patients on RRT.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.